Swiss Market Community

1. Catalysts Evenamide (Schizophrenia Add-On Therapy): The key growth catalyst for Newron is Evenamide, a novel glutamate-modulating drug in Phase III development for treatment-resistant schizophrenia (TRS).

Valuation ### **Analyse der Roche Jahreszahlen 2024: Wachstum setzt sich fort, Herausforderungen bleiben_20250130 #### Zusammenfassung der Ergebnisse Roche hat für das Jahr 2024 ein solides Wachstum von 7 % auf 60,5 Mrd. CHF erzielt, was die Erwartungen leicht übertroffen hat.

Catalysts Preliminary Unaudited Revenue and Cash Revenue: €266.8 million, representing a year-on-year increase of 188% compared to €92.8 million in 2023. This includes significant project-based revenues from GI Genius™ and Winlevi® of €190.2 million.

211011 Draupnir noch ein Anteil von rund 55,5% an Polypeptide. Der «Free Float» an der Börse SIX erhöht sich dadurch gleichzeitig von 40,0 auf rund 44,5%.

Key Takeaways Expansion in sustainability, digital trust, and compliance services positions SGS to benefit from global regulatory trends and growing demand for third-party assurance. Integration of acquisitions and efficiency programs enhance service offerings, operational flexibility, and margin expansion in regulated, high-growth sectors.

Key Takeaways Expansion into high-growth regions and enhanced traveler engagement strategies are set to drive diversified revenue growth and higher margins. Integration synergies and disciplined cost management are expected to improve operating efficiency and boost free cash flow.

Key Takeaways Strategic focus on specialties, mid-market, and specialty insurance, coupled with digital investment, is set to drive revenue growth and boost operational efficiency. Demographic shifts and technology adoption support Zurich's expansion in life protection and specialty products, ensuring resilient margins and improved customer retention.

Key Takeaways Huber+Suhner's innovation in optical switches and fiber technology could drive significant growth in the data center segment, boosting future revenues and margins. Strong market position in electric vehicle charging and aerospace defense, along with global expansion strategies, signifies potential for long-term revenue and market share growth.

Key Takeaways Growth in aseptic packaging and expansions in India and China may improve supply chain efficiencies, reduce costs, and increase net margins. Commitment to sustainability and innovation in product lines may enhance customer loyalty, increase market share, and support long-term revenue growth.